Skip to search formSkip to main contentSkip to account menu

dabigatran

Known as: Dabigatran [Chemical/Ingredient], N-((2-(((4-(aminoiminomethyl)phenyl)amino)methyl)-1-methyl-1H-benzimidazol-5-yl)carbonyl)-N-2-pyridinyl-beta-alanine 
A THROMBIN inhibitor which acts by binding and blocking thrombogenic activity and the prevention of thrombus formation. It is used to reduce the risk… 
National Institutes of Health

Related topics

Related topics

16 relations

Broader (1)

Antithrombins

Narrower (4)

BIBR 1048Pradaxadabigatran etexilatedabigatran etexilate mesylate
Dabigatran:ACnc:Pt:PPP:Qn:ChromoDabigatran:MCnc:Pt:PPP:Qn:CoagDabigatran:MCnc:Pt:Ser/Plas:QnIn Blood

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Clinical Benefit of Direct Oral Anticoagulants Versus Vitamin K Antagonists in Patients with Atrial Fibrillation and Bioprosthetic Heart Valves.
Review
2019
Review
2019
A New Option for Reversing the Anticoagulant Effect of Factor Xa Inhibitors: Andexanet Alfa (ANDEXXA).
2019
2019
Patients with higher body mass index treated with direct / novel oral anticoagulants (DOAC / NOAC) for atrial fibrillation experience worse clinical outcomes.
Highly Cited
2018
Highly Cited
2018
Three-Year Clinical Outcomes Associated With Warfarin vs. Direct Oral Anticoagulant Use Among Japanese Patients With Atrial Fibrillation　- Findings From the SAKURA AF Registry.
BACKGROUND Although direct oral anticoagulants (DOACs) are widely used in Japanese patients with atrial fibrillation (AF), large… 
2015
2015
Hemorrhagic complications of dental extractions in 181 patients undergoing double antiplatelet therapy.
Highly Cited
2013
Highly Cited
2013
Higher Persistence in Newly Diagnosed Nonvalvular Atrial Fibrillation Patients Treated With Dabigatran Versus Warfarin
Background—Oral anticoagulation therapy is the primary tool in reducing stroke risk in patients with nonvalvular atrial… 
Highly Cited
2013
Highly Cited
2013
Abstract 17765: A Specific Antidote for Dabigatran: Immediate, Complete and Sustained Reversal of Dabigatran Induced Anticoagulation in Healthy Male Volunteers
INTRODUCTION: The new oral anticoagulants are effective alternatives for warfarin but specific antidotes are not yet available… 
2012
2012
Do new oral anticoagulants require laboratory monitoring? The clinician point of view.
2012
2012
Head-to-head or indirect comparisons of the novel oral anticoagulants in atrial fibrillation: What’s next?
Head-to-head or indirect comparisons of the novel oral anticoagulants in atrial fibrillation: What’s next? - 
2011
2011
New options in anticoagulation for atrial fibrillation.
The presence of atrial fibrillation significantly increases the risk and burden of thromboembolic stroke.1 Warfarin is the… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)